CANN GLOBAL LIMITED has not announced any current capital raises, but we are collecting interest for future raises.
1. Create Account
Complete your onboarding digitally in less than 3 minutes.
2. View Terms
View the full term sheet for the capital raise.
3. Bid for Allocation
Submit and track your bid online.
The Group’s primary focus is to legally grow and cultivate hemp to research and develop medicinal cannabis products to service an increasing demand in the Australian and global markets. Cann Global Ltd has a 100% shareholding in Medical Cannabis Ltd (MCL) and Medcan Australia Pty Ltd (Medcan) which operate a business cultivating, researching, developing and soon to be distributing medicinal cannabis products in Australia. Our Medical Cannabis division has been a key value driver for the Group. The Group also retains an interest in its existing Bauxite Projects.
24 Birriga Rd, Bellevue Hill NSW 2023, Australia
Fresh Equities does not have CANN GLOBAL LIMITED quarterly cash flows data.